Get Vera Therapeutics alerts:View Our Latest Report on VERAVera Therapeutics Stock PerformanceShares of VERA opened at $30.76 on Tuesday. Vera Therapeutics has a 52 week low of $19.93 and a 52 week high of $56.05. Vera Therapeutics (NASDAQ:VERA – Get Free Report) last posted its quarterly earnings data on Monday, August 10th. Vera Therapeutics Company Profile(Get Free Report)Vera Therapeutics is a clinical-stage biotechnology company focused on developing novel immunotherapies that harness the body’s own regulatory T cells to treat autoimmune and inflammatory diseases. Further ReadingReceive News & Ratings for Vera Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vera Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.